Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh Subrahmanyam

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Nature Immunology|October 30, 2012
Localized epigenetic changes induced by DH recombination restricts recombinase to DJH junctionsRamesh Subrahmanyam, Hansen Du, Irina Ivanova, et al.
The Journal of Experimental Medicine|May 6, 2009
A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activationTirtha Chakraborty, Thomas Perlot, Ramesh Subrahmanyam, et al.
The Oncologist|July 10, 2025
Clinical response to novel combination of trastuzumab deruxtecan and abiraterone in HER2-expressing metastatic castration-resistant prostate cancerRithika Rajendran, Coen J Lap, Siddharth Madapoosi, et al.
American Journal of Hematology|July 18, 2024
Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War erasAndrew Tiu, Zoe McKinnell, Shanshan Liu, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Historical Perspective of HER2 Testing and Treatment in Prostate CancerNatalia Zamalloa, Jacqueline Rose, Coen J Lap, et al.
Annals of Internal Medicine|November 4, 2024
Response of Human Epidermal Growth Factor Receptor 2-Expressing Prostate Cancer to Trastuzumab DeruxtecanCoen J Lap, Rithika Rajendran, Jose Manuel Martin, et al.
Annals of Diagnostic Pathology|April 16, 2024
The prevalence and clinical significance of HER2 expression in prostate adenocarcinomaFayez Estephan, Coen J Lap, Jeff Banagan, et al.
Ethnicity & Disease|April 10, 2020
Why African Americans say "No": A Study of Pharmacogenomic Research ParticipationMohammed Nooruddin, Courtney Scherr, Paula Friedman, et al.
Plos One|March 28, 2008
p16(INK4a) translation suppressed by miR-24Ashish Lal, Hyeon Ho Kim, Kotb Abdelmohsen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nature Immunology|October 30, 2012
Localized epigenetic changes induced by DH recombination restricts recombinase to DJH junctionsRamesh Subrahmanyam, Hansen Du, Irina Ivanova, et al.
The Journal of Experimental Medicine|May 6, 2009
A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activationTirtha Chakraborty, Thomas Perlot, Ramesh Subrahmanyam, et al.
The Oncologist|July 10, 2025
Clinical response to novel combination of trastuzumab deruxtecan and abiraterone in HER2-expressing metastatic castration-resistant prostate cancerRithika Rajendran, Coen J Lap, Siddharth Madapoosi, et al.
American Journal of Hematology|July 18, 2024
Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War erasAndrew Tiu, Zoe McKinnell, Shanshan Liu, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Historical Perspective of HER2 Testing and Treatment in Prostate CancerNatalia Zamalloa, Jacqueline Rose, Coen J Lap, et al.
Annals of Internal Medicine|November 4, 2024
Response of Human Epidermal Growth Factor Receptor 2-Expressing Prostate Cancer to Trastuzumab DeruxtecanCoen J Lap, Rithika Rajendran, Jose Manuel Martin, et al.
Annals of Diagnostic Pathology|April 16, 2024
The prevalence and clinical significance of HER2 expression in prostate adenocarcinomaFayez Estephan, Coen J Lap, Jeff Banagan, et al.
Ethnicity & Disease|April 10, 2020
Why African Americans say "No": A Study of Pharmacogenomic Research ParticipationMohammed Nooruddin, Courtney Scherr, Paula Friedman, et al.
Plos One|March 28, 2008
p16(INK4a) translation suppressed by miR-24Ashish Lal, Hyeon Ho Kim, Kotb Abdelmohsen, et al.
Pageof 2